Company: SXTPW
Filing Date: 2025-01-30
Form Type: 424B5
Source: 0001213900-25-008098
Chunk: 35

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-01-30
Form: 424B5
Chunk 35
---
 $            | (38,482,920 | ) |     |                | (38,482,920 | ) |
| Total                                                                                                                               
 stockholders’ equity                                                                                                                |     | $      |   5,962,847 |   |     | $            |   6,068,844 |   |     |                |   6,874,276 |   |
| Total                                                                                                                               
 capitalization                                                                                                                      |     | $      |   7,420,893 |   |     | $            |   7,423,348 |   |     |                |   8,226,780 |   |

| (1) | Does                       
 not include the following: |

| ● | 285,373                                                           
 shares of common stock reserved for issuance under the 2022 Plan; |

| ● | 688,165                                                                                                                            
 shares of common stock issuable upon exercise of outstanding stock options at a weighted average exercise price of $2.78 per share |

| ● | 846,438                                                                                                                         
 shares of common stock issuable upon exercise of outstanding warrants at a weighted average exercise price of $26.01 per share; |

| ● | 444,000                                                                                          
 shares of common stock issuable upon the exercise of outstanding Pre-Funded Warrants to purchase 
 common stock at an exercise price of $0.001 per share;                                           |

| ● | 2,898,551                                                                                     
 shares of common stock issuable upon exercise of outstanding Series A warrants at an exercise 
 price of $1.38 per share;                                                                     |

| ● | 2,898,551                                                                                     
 shares of common stock issuable upon exercise of outstanding Series B warrants at an exercise 
 price of $1.38 per share;                                                                     |

| ● | 7,076                                                                                                                                    
 shares of common stock issuable upon exercise of the representative warrants issued to the representative in our initial public offering 
 in July 2023 at an exercise price of $5.082 per share;                                                                                   |

| ● | 31,300                                                                                                                               
 shares of common stock issuable upon exercise of the representative warrants to the representative in our public offering in January 
 2024 at an exercise price of $69.96 per share;                                                                                       |

| ● | 217,391                                                                                                                          
 shares of common stock issuable upon exercise of the warrants issued to the placement agent in our private placement offering in 
 September 2024 at an exercise price of $1.